IRIS
BASILE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.213
EU - Europa 1.170
AS - Asia 790
SA - Sud America 145
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 18
Totale 3.396
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.130
RU - Federazione Russa 686
SG - Singapore 268
CN - Cina 264
IT - Italia 188
BR - Brasile 117
HK - Hong Kong 78
VN - Vietnam 70
DE - Germania 56
SE - Svezia 54
CA - Canada 41
FR - Francia 41
IN - India 34
GB - Regno Unito 32
FI - Finlandia 30
NL - Olanda 22
MX - Messico 19
JP - Giappone 18
PL - Polonia 15
BD - Bangladesh 14
ES - Italia 11
ID - Indonesia 9
IQ - Iraq 8
JM - Giamaica 8
ZA - Sudafrica 8
AR - Argentina 7
EC - Ecuador 7
IE - Irlanda 6
BE - Belgio 5
LT - Lituania 5
TR - Turchia 5
VE - Venezuela 5
CO - Colombia 4
UA - Ucraina 4
UZ - Uzbekistan 4
AT - Austria 3
CR - Costa Rica 3
GT - Guatemala 3
MD - Moldavia 3
MY - Malesia 3
PH - Filippine 3
SA - Arabia Saudita 3
TN - Tunisia 3
BB - Barbados 2
MA - Marocco 2
NP - Nepal 2
PK - Pakistan 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
NI - Nicaragua 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
VC - Saint Vincent e Grenadine 1
Totale 3.338
Salva come PNG Salva come JPEG
Città #
Singapore 155
Ashburn 151
Dallas 130
San Jose 117
Moscow 101
Hong Kong 76
New York 65
Shanghai 45
Milan 44
Beijing 40
Council Bluffs 37
Los Angeles 37
Munich 30
Boardman 29
Ho Chi Minh City 29
Phoenix 27
Hefei 25
Turku 23
Santa Clara 22
Lauterbourg 20
Rome 17
Denver 15
São Paulo 15
Hanoi 14
Brooklyn 13
Tokyo 13
Montreal 12
Orem 12
Warsaw 12
Guangzhou 11
Lawrence 11
Princeton 11
Mexico City 10
Amsterdam 9
Atlanta 8
Chennai 8
Frankfurt am Main 8
Miano 8
Pune 8
Houston 7
Johannesburg 7
London 7
Manchester 7
Toronto 7
Bar Harbor 6
Columbus 6
Mumbai 6
Seattle 6
The Dalles 6
Turin 6
Da Nang 5
Dublin 5
Helsinki 5
Kingston 5
Memphis 5
Nuremberg 5
Salerno 5
San Francisco 5
Stockholm 5
Barnet 4
Brussels 4
Catania 4
Charlotte 4
Erbil 4
Falkenstein 4
Guayaquil 4
Haiphong 4
Hyderabad 4
Las Vegas 4
Poplar 4
Shenzhen 4
Tashkent 4
Washington 4
Baltimore 3
Belo Horizonte 3
Bologna 3
Boston 3
Buffalo 3
Caxias do Sul 3
Cesano Boscone 3
Hanover 3
Jackson 3
Naples 3
Querétaro 3
Rio de Janeiro 3
Riyadh 3
Verona 3
Acalanes Ridge 2
Ankara 2
Bexley 2
Biên Hòa 2
Brampton 2
Brescia 2
Bridgetown 2
Bến Tre 2
Cagliari 2
Cancello e Arnone 2
Caracas 2
Carpi 2
Cerano 2
Totale 1.658
Salva come PNG Salva come JPEG
Nome #
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 194
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 176
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 152
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 151
A global approach to improving penile cancer care 149
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 142
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 137
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 135
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 134
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 132
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 130
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 128
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 127
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 122
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 122
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 121
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 120
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 119
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 113
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 111
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 111
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 101
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 93
The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis 87
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 78
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer 56
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) 48
Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer 25
Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer (SURE-02): a single-arm, phase 2 study 24
Data from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial 23
Diagnostic and treatment delays in penile cancer: a call to improve awareness and referral 22
Tumor Mutational Burden Predicts the Outcome of Patients With Muscle-invasive bladder Cancer Undergoing Immune-checkpoint Inhibitor-Based Neoadjuvant Therapy 12
null 1
Totale 3.396
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 0 6 2 0 1 0 1 0 0 9
2022/2023100 27 18 3 7 4 12 8 11 2 0 4 4
2023/2024241 12 20 22 19 15 47 1 40 5 9 14 37
2024/2025483 33 21 16 29 31 41 66 62 70 28 32 54
2025/20262.049 121 124 125 240 182 67 156 188 573 131 68 74
2026/2027495 45 94 134 222 0 0 0 0 0 0 0 0
Totale 3.396